It has been previously reported that SPRY2 overexpression inhibited the induction of the transcriptional repressor E-cadherin in the SKOV3 ovarian adenocarcinoma cell line (Cheng et al., 2016). Here, SPRY2 is linked to ovarian adenocarcinoma.